CA2180166A1 - Wafer having adhesive skin barrier layer and production method therefor - Google Patents

Wafer having adhesive skin barrier layer and production method therefor

Info

Publication number
CA2180166A1
CA2180166A1 CA002180166A CA2180166A CA2180166A1 CA 2180166 A1 CA2180166 A1 CA 2180166A1 CA 002180166 A CA002180166 A CA 002180166A CA 2180166 A CA2180166 A CA 2180166A CA 2180166 A1 CA2180166 A1 CA 2180166A1
Authority
CA
Canada
Prior art keywords
web
wafer
barrier material
mound
skin barrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002180166A
Other languages
French (fr)
Inventor
Ronald S. Botten
Larry R. Decamp
Calla K. Stoick
Eric D. Ellingson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hollister Inc
Original Assignee
Hollister Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24029097&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2180166(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hollister Inc filed Critical Hollister Inc
Publication of CA2180166A1 publication Critical patent/CA2180166A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0276Apparatus or processes for manufacturing adhesive dressings or bandages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • A61F13/0226Adhesive plasters or dressings having a fluid handling member characterised by the support layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0246Adhesive plasters or dressings characterised by the skin adhering layer
    • A61F13/0253Adhesive plasters or dressings characterised by the skin adhering layer characterized by the adhesive material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/44Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices
    • A61F5/443Devices worn by the patient for reception of urine, faeces, catamenial or other discharge; Portable urination aids; Colostomy devices having adhesive seals for securing to the body, e.g. of hydrocolloid type, e.g. gels, starches, karaya gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00089Wound bandages
    • A61F2013/00153Wound bandages coloured or with decoration pattern or printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00655Plasters adhesive
    • A61F2013/00676Plasters adhesive hydrogel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00727Plasters means for wound humidity control
    • A61F2013/00748Plasters means for wound humidity control with hydrocolloids or superabsorbers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00727Plasters means for wound humidity control
    • A61F2013/00757Plasters means for wound humidity control with absorbent adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/15203Properties of the article, e.g. stiffness or absorbency
    • A61F2013/15284Properties of the article, e.g. stiffness or absorbency characterized by quantifiable properties
    • A61F2013/15292Resistance, i.e. modulus or strength
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F2013/8488Accessories, not otherwise provided for, for absorbent pads including testing apparatus
    • A61F2013/8491Accessories, not otherwise provided for, for absorbent pads including testing apparatus including test methods
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10Methods of surface bonding and/or assembly therefor
    • Y10T156/1002Methods of surface bonding and/or assembly therefor with permanent bending or reshaping or surface deformation of self sustaining lamina
    • Y10T156/1039Surface deformation only of sandwich or lamina [e.g., embossed panels]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T156/00Adhesive bonding and miscellaneous chemical manufacture
    • Y10T156/10Methods of surface bonding and/or assembly therefor
    • Y10T156/1052Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
    • Y10T156/108Flash, trim or excess removal

Abstract

An adhesive wafer is disclosed having a thin barrier layer of soft, pliant adhesive material with particles of one or more hydrocolloids dispersed therein. A flexible and preferably stretchable cover layer extends along one side of the barrier layer and a removable release sheet protects the opposite side of the barrier layer. The wafer has a central zone and a relatively large outer zone surrounding that central zone, with the material of the barrier layer in the outer zone having generally uniform molecular orientations in radial directions over an arc of 360 degrees and being of relatively uniform tensile strength in all such radial directions. Also disclosed are injection/compression molding methods for making such wafers.

Description

-~4~ 2~
NAFER ~AVING ADHESIVE SKIN BARRIER LAYER
AND PRO~UCTION 1"FTHOD TIT~F FOR
Backaround Adhesive skin barrier materials are widely known in l:he medical field for use in ostomy faceplates, wound dressings, and skin-contacting gaskets or liners of various shapes and sizes, all of which may be generally referred to as hydrocolloid-containing wafers or dressings. A characteristic feature of such wafers is the presence of a skin-contacting layer of a soft, pliant adhesive material which has both dry and wet tack and which contains a dispersion of hydrocolloid particles capable of absorbing a~[ueous fluids and of swelling as such absorption takes place. One side of such a wafer us-lally has a cover layer of film or fabric, and the opposite side o~
the barrier layer is protected until use by a release sheet of s;l;co~;2ed paper or other suitable material. An example of one such wafer or dressing is ~l;c~locod in patent 4,738,257.
Paten~ 4,738,257 discloses a wafer in which the hydrocolloid-containing adhesive layer is of substantially uniform th;rl~nes~ but in recent years contoured wafers have become available in which the hydrocolloid-containing layers are not of uniform thickness. Patents 5,133,821 and 4,867,748 disclose contoured wafers in which the hydrocolloid-containing }~arrier layers have relatively thick central body portions but then taper outwardly to terminate in peripheral edges or flanges of reduced thickness.
Whether contoured or not, all such wafers are believed to be produced in essentially the same way. A
hydrocolloid-containing barrier material is simply extruded onto a web (which, following die cutting, may ultimately become the removable release sheet or the cover sheet f or the finished wafer) and is then covered by a second web (which, following die cutting, may become the other outer layer for the wafer). If the wafers are to be contoured then, as disclosed in patent 5,133,821, the contouring operation may be undertaken _ _ _ _ _ -218016~
prior to addLtion of the second web. Such contouring may be achieved by means of a roller (as in patent S,133,821) or by a vertical press but, in either case, the contouring operation is performed on what is in effect a multi-layer sandwich in which the hydrocolloid-containing core layer of that sandwich has been extruded .
There are major disadvantages to a process requiring the extrusion of hydrocolloid-containing barrier materials, some of which have been well recognized in the past and others of which are only now being discovered. Skin barrier materials are generally expensive and substantial quantities of such materials are n~c~fi~rily wasted because they become scrap in the final die-cutting operations. Wastage is particularly evident where the wafers are circular in outline, but such wastage also occurs to a substantial extent even for wafers of more rectangular shape .
Another disadvantage lies in the fact that making a contoured wafer with extruded barrier material is essentially a two step operation, the first step being the extrusion of a layer of barrier material of uniform thickness and the second step then being the ~ s~ion of the barrier material into the desired contour. The requirement for successive processing steps provides its own complexities in terms of operating uceduL~ and the physical size of the production eguipment required. Additional problem areas involve keeping the freshly-extruded barrier material from sticking to the contouring roller. As disclosed in patent 5,133,821, a web of processing paper may be interposed between the barrier material and the contouring roller to prevent such sticking from taking place but, in that case, the processing web is generally stripped from the barrier after the contouring procedure and must be replaced by a web of different material which ultimately becomes the cover film of the final product. The need to use different web materials for processin~ ~contouring) and for producing the final film (because the physical characteristics of the processing paper used for contouring may not be the properties desired as the outer film in the final product) presents additional complications and added expense.

_ _ _ _ _ _ _ . . . . . . . . . . . . _ _ .. . _ .. . _ .. _ ..

21 ~01 66 In general, production methods for making adhesive wafers from extruded skin barrier materials require high-production equipment and long production runs with a minimum of interruptions. The very nature of such operations make quick changeover and interrupted operations difficult and impractical.
The result is that spe~ iAli7ed products of more limited demand, but nevertheless fulfilling important patient needs, may not reach the marketplace because production realities preclude their manufacture.
Finally, extrusion of skin barrier materials is now found to have a further disadvantage relating to the final products, their physical characteristics, and their performance. In the manufacture of extruded materials there is what is commonly known as "machine" direction and "cross" direction. The process of extrusion tends to orient molecules (also fibrous particles that may be included in the barrier composition) longit~ in:~lly in the direction of extrusion. Such parallel orientation means that properties that may be important in the performance of a wafer or dressing when it is used by a patient may not be uniform but instead may vary considerably d~ponA;n~ on whether such properties are being measured in the machine direction or in the cros6 direction. For example, Figure 1 depicts a barrier layer (exclusive of cover or release layers) of a conventional extruded wafer of uniform barrier thirkn-~cs. The machine direction M is schematically illustrated by tiny striations oriented in parallel with the direction of extrusion, whereas the cross direction C is at right angles to the orientation of the striations. Such striations may take the form of filler particles of cotton or other f ibrous additives, but such striations also represent the pr~d~ ; n~nt direction of molecular orientation so that, even without the inclusion of a fibrous filler, properties in directions ~ and C tend to be different.
Where such properties af fect the strength of the barrier material (both prior to and following hydration), or the tendency to shrink in storage, or the rate of absorption or erosion, or the routes of saturation, swelling and/or leakage, the lack of uniformity in one direction versus another may have serious shortcomings.

~1~0~6 ,~
S~ rv of the Inventi~n This invention lies in the discovery that the production and product disadvantages arising from conventional extrusion techniques for making skin barrier wafers may be overcome by a combination of injection and ~- t s:,ion molding procedures. It has now been discovered that the injection/compression molding of skin barrier wafers by our methods results in products having far more uniform physical characteristics (when measured in all radial directions in a 360 degrees arc about the centerpoint of a wafer) and also results in a production process that, in comparison with extrusion processes, has the advantages of being more economical with little or no wastage of barrier material, being easily adaptable for short production runs requiring only momentary downtime between runs, being ideally suited for successive runs in the manufacture of wafers of different sizes, shapes, and contours, being unlikely to present the sticking problems associated with the contouring of extruded wafers and the relatively expensive steps that have been taken in the past to avoid or reduce such sticking problems, and providing a relatively compact and efficient system for processing high quality wafers which may be combined with subsequent processing stations resulting in the production o~ f inished articles, whether they be ostomy pouchs equipped with such wafers, wound dressings, or other medical products.
Briefly, the method includes the steps of first depositing a mass or mound of soft, deformable skin barrier material (pre~erably heated to increase its flowability) onto a first web extending generally along a horizontal plane and supported by a rigid first platen beneath the web, subsequently or simultaneously locating a flexible second web a spaced distance above the f irst web and the mound with the second web back(sd by a rigid second platen positioned directly thereabove, and thereafter reducing the spacing between the first and seco~d platens and c~ :~ssing the mound of skin barrier material to displace a major portion of that material radially outwardly in directions extending 360 degrees about the original location of the deposit. At least one of the platens has a mold cavity of selected shape facing in the direction of the webs, with tlle i. ~.. ~ 2180166 cavity having an outline defining the shape of a wafer and the mound being located at the center of that cavity at the -n~ - -nt of the ~_ ressing step. Wastage of barrier material is avoided or severely limited because only a predet~rm; n~cl amount of barrier material is deposited in the ~irst step, such amount being suf f icient only to cause displacement of the barrier material up to the outer limits, or pos~slbly slightly beyond the outer limits, of the mold ca~ity during the compressing step.
Where the depositing and locating steps are performed simultaneously, the second web is provided with an aperture through which the skin barrier material is inj ected onto l:he receiving surface of the first web. In a preferred: o~l;r-nt of the operating procedure, the step of locating the secolld web above the first web occurs immediately following the depositing step, the depositing step occurring at a first operating station and the web locating and compressing steps occurring at a second operating station. Because the depositing and compressing steps occur at different operating stations, it is therefore nnc.~eccAry to provide the second web with the injection aperture reguired by the other . ~oflir-nt of the operatin~
method .
The operation is intermittent but continuous with the webs being indexed forward and carrying the partially-finished wafers onto one or more s~hseg~ nt processing stations.
A final station involves the cutting of finished wafers from the web-barrier-web sandwich along the outer margins of the barrier layers, but other stations may also be involved. For example, a printing station ( in which suitable indicia may be imprinted on one or both of the outer layers) may precede the cutting station. Also, while the finished wafers may be placed in storage for further processing, such additional processing may instead take place immediately following the cutting operation, with the barrier-manufacturing procedures constituting a part of a more F.n~ _ Csing manufacturing operation. For example, as each wafer is completed by the processing steps of this invention, it may be attached to a pouch to produce a f inished ostomy appliance (or other type of collection appliance) and may 2~80~66 then be packaged for distribution.
Other features, objects, and advantages of the invention will become apparent from the specification and drawings.
Drawi naq Figure 1 is a plan view of the barrier layer of a conventional wafer produced by conventional extrusion techniques .
Figures 2 and 3 are perspective views of typical wafers that may be produced by the inj ection/compression molding procedures of this invention.
Figure 4 is a sectional view taken along line 4-4 of Figure 2.
Figure 5 is a schematic plan view similar to Figure ~ but showing the planar barrier layer of a wafer embodying this invention and made by the method(s) disclosed herein.
Figure 6 is a key for analyzing the charts of Figures 7 and 8.
Figure 7 is a chart showing the tensile stress characteristics at 10 percent elongation comparing skin barrier samples of the same composition, one batch being made by a conventional extrusion method and the other batch being made by the injection/compression molding method of this invention.
Figure 8 is a chart showing the tensile stress characteristics at 100 percent elongation comparing skin barrier samples of the same composition (but different than the composition of Figure 7), one batch being made by a conventional extrusion method and the other being made by the injection/_ ~ssion molding of this invention.
Figure 9 is a schematic view illustrating equipment for carrying out the method of this invention.
Figures 10-13 are enlarged rL_ ~ tary views, shown partially in section, illustrating successive steps in performing the method of this invention.
Figure 14 depicts the web characteristics required for carrying out a production method constituting a second embodiment of this invention.
Figure 15 schematically illustrates the simultaneous depositing and locating steps of the method constituting the 218~t66 second embodiment.
Figure 16 depicts the compres5ing step of the second - ~ir L.
Flgures 17 and 18 illustrate finished wafers which are identical to each other except for the location o~ the peripheral cut (that defines the outer edges of the wafers) in relation to the outer limits of the barrier layers.
Det~;led Descri~tion of Preferred E~hn~lir-nts In terms of appearance, wafers made in accordance with this invention may be outwardly similar to wafers made by conventional methods in which the barrier layers are extruded.
Such wafers may be flat or contoured; may be circular, oval, trapezoidal or rectangular (the latter two shapes usually having rounded edges) in outline: may be flat or concavo-convex in section; and may or may not have central op~n; ns$. For e~cample, Figures 2 and 4 depict a contoured wafer 10 having a core layer 11 of hydrocolloid-containing skin barrier material and outer layers 12 and 13. Layer 12 is a removable release sheet ~ormed of siliconized paper or other suitable material, whereas layer 13 is a backing layer or cover layer that remains attached to the barrier layer as a p~rr~n~nt ~ nt of the wafer. The cover layer 13 may be ~ ,-9ecl of a polymeric film, such as polyurethane or polyethylene, or a woven or nonwoven fabric (porous or non-porous), or a layer of flexible polymeric ~oam (open cell or closed cell), or any other sheet materials having similar properties, or a combination of such materials. While a contoured wafer is shown in Figures 2 and 4, it is to be understood that the contour of any wafer made by the methods disclosed herein may be different than that shown or, if desired, may have planar side surfaces with no contour at all.
Figure 3 shows a wafer 10' identical to the wafer 10 of Figure 2 except for the provision of a central opening 14. In the following discussion, for purposes of illustration, outer layers 13, 13 ' will be considered as being formed of soft, microporous, nul~ uv~l-, heat-sealable fabric and layers 12, 12' will be considered as being formed of siliconized release paper but, as explained, the character of the materials used fo these layers may be varied dPr~n~l;n~ on the requirements for and the ~1 sa~
>
intended uses of the finished wafers.
The term "skin barrier" material is widely used in the medical field to refer to any of a variety of materials in which a sticky, pliant adhesive composition constitutes a continuous phase and particles of one or more liquid-absorbing and swellable hydrocolloids are dispersed thLVU~ U~ the adhesive and constitute a discontinuous phase. The adhesive phase commonly contains polyisobutylene, often in combination with one or more tackifiers, plasticizers, and antioxidants. An elastomer such as a ~l.yL~ isopyrenc ~y.e~le block copol~mer (e.g., "Cariflex" TR-1107, from Shell Chemical Co.) or a styrene-butadiene-styrene block copolymer (e.g., "Kraton" 1100 Series, from Shell 'h~ l Co. ) may be included, and other A13A
block copolymers, such as ethylene-propylene block copolyners known as EPR rubbers have also been included in adhesive compositions for increasing the elastomeric properties of such barrier materials.
The discontinuous phase may be particles of any suitable hydrocolloid or mixtures of hydrocolloids such as sodium caLb~,~y thylcellulose, calcium carboxymethyl- cellulose, pectin, gelatin, and natural gums such as gum guar, gum a~-abic, locust bean gum, karaya, and the like. Such hydrocolloids are water-absorbing and water- swellable. They absorb moistu~e ~rom the skin and contribute to the wet tack characteristics O c the skin barrier material, all as well known in the art.
When such a skin barrier material becomes hydrated, its consistency becomes more gel-like and a phase change usually takes place. The water and hydrated hydrocolloids converl: to become the continuous phase and the water-insoluble adhesive -nts, such as the polyisobutylene, become the discontinuous phase. Regardless of the stage of hydration, and even prior to hydration, it is important that the physical characteristics of a wafer be similar in all radial direcl;ions.
One easily-measured parameter is tensile strength, but other related characteristics such as shrinkage in storage, expansion on hydration, erosion in the presence of agueous fluids, and absorption of such fluids of a skin barrier wafer should under ideal circumstances also be similar in all radial directions.
_ g _ ,, , , ~tsal66 - A5 indicated by tensile strength measurements, it is now believed that such objectives are achieved far more effectively by a wafer made by the inj ection/compression molding methods disclosed herein than a wafer ~ 'CPd of the same skin ba~:rier material made by a conventional extrusion process. The differences in one parameter, tensile strength, are reflec~ed by the charts of Figures 7 and 8 and by the explanatory schematics of Eigures 1, 5 and 6.
Figure 1 shows a disc 20 of skin barrier material formed by conventional extrusion te~ hn~ . M represents the machi~e direction and C designates the cross direction, with striations 21 schematically depicting the molecular orientation that ~ends to result from the extrusion process. Such orientations are predominately in the direction of flow.
Figure 5 shows a similar barrier disc 20' made in accordance with the process depicted in Figures 9-13 but with the outer layers removed, leaving only the barrier layer of substantially uniform ~h;ckn~cs. Radially extending striations 21' 6chematically depict a generally uniform molecular orientation in radial directions of f low over an arc or sw,eep of 360 degrees in what constitutes a relatively large annular outer portion or zone 22 of the disc. It is believed that in th(s relatively small central region 23 (or region at the center of mass) of the disc, the molecules may be more randomly oriented for reasons that will become apparent as the specification proceeds .
The differences in the tensile characteristics of the respective barrier discs when measured in different radial directions will become evident from the following illustrative examples:
~Y;-~-le 1 Samples of extruded barrier material were compared with samples of the same barrier material made by the process of this invention. The barrier material was a commercial composition r-rk~ted under the designation "Guardian" by Hollister InCoL~UL .ted, Libertyville, Illinois. Such barrier material contains polyisobutylene as the primary adhesive in which particles of selected hydrocolloid materials are dispersed. A

218~166 , ~ , .t .
small quantity, less than 9% by weight, of cotton fibers are also included to provide greater internal strength. Such barrier composition is commercially used for ostomy appliances and effectively absorbs moisture and stomal fluids. Its elastomeric properties are not as great as some other skin barrier materials, although discs formed of "Guardian" barrier composition are flexible and pliant.
Rectangular samples corrPspon~in~ to A, B, C, D and E and measuring 1. 0 by 2 . 0 inches were cut as depicted on discs 20 and 20' in Figures 1 and 5. Ten samples A of extruded barrier material were cut with their greater dimension extending in the machine direction, and ten samples B of extruded barrier material were cut with their greater dimension extending in the cross direction.
Three samples of identical size t 1. 0 by 2 . 0 inches) were cut from each of ten discs 20', making a total of ten each of samples C, D and E as represented in Figure 5. As shown therein, samples C and E extended radially at 90- with respect to each other, and sample D of each disc 20' extended radially at 45 in relation to the proj ected longitudinal axes of samples C and E.
Figure 7 plots the tensile stress measurements of all samples at 1096 elongation using an Instron Series IX Automated Materials Testing System 6 . 05. The jaws of the machine gripped the ends of each sample at an initial distance of 1 inch apart tso that the "tested" portion of each sample measured 1. 0 by 1. 0 inches), and such jaws were then separated at a crosshead speed of 2 . 5 inches per minute . Although the thickness of the samples cut from the extruded material were slightly thinner than the samples cut from the injection/compression molded materials t0-069 and 0.070 inches, respectively), all tensile stress mea~ s allowed for that difference by being computed in pounds per square inch tpsi).
Figure 6 is a key that explains the characters appearing in the charts of Figures 7 and 8. In each case, the vertical line 25 represents what is referred to statistically as the "confidence interval" with its upper and lower limits representing the highest psi and the lowest psi for 9596 of the .

samples in any given batch of samples A through E, respectively.
Line 27 is the mean psi for any given batch.
The chart reveals that the full range of tensile stress measurements of extruded Guardian barrier samples A testec~ in the machine direction was far above the full range of tensile stress mea:~u~ ~s for samples B tested in the cross direction.
The mean tensile stress in the cross direction was 12 . 6 psi for samp~es B in contrast to a mean of 20. 4 psi for extruded samples measured in the machine direction, the difference therefore being 7 . 8 psi. In contrast, the samples cut from injection/~ Iession molded discs 20' at 0- (E), 45- (D) and 90- (C) were similar, with the maximum difference in the mean measurements for the samples of the respective batches C, D and E being no more than 0. 2 psi.
le 2 A test similar to that described in Example 1 was conducted using a more elastomeric barrier material available as "~lextend" from Hollister In.;o~oLated, Libertyville, Illinois.
Unlike "Guardian, " such material contains no cotton fibers or any other fibrous filler. Tensile stress was measured for all of the samples at 100% elongation. Again, with respect to the extruded samples, no overlap in any of the tensile stress measurements between the 10 samples of batch A (measured in the machine direction) and those of batch B (measured in the cross direction) oc~;-,L~d. The difference in the mean tensile stress figures for those two batches was 3 . 5 psi. By contrast, the maximum difference between the mean tensile stress figures for samples C, D and E was only about 0.25 psi.
The results of the tensile ~Lc~ tests described in Examples 1 and 2 and illustrated in Figures 7 and 8 therefore reveal that skin barriers made in accordance with the procedures disclosed herein result in discs in which the strength characteristics of the barrier materials in different radial directions are substantially the same, in contrast to large differences that exist when an extruded barrier is measured radially in machine and cross directions. Such uniformity of barriers made by the injection/compression molding procedures of ~180166 . ~ . ~, . . .
this invention is believed to be associated with greater uniformity in radial directions of other characteristics that are important in barrier behavior and performance. For example, barrier materials are often subj ect to shrinkage in storage and it has been noted that with extruded barriers such shrinkage tends to be greater in a machine direction than in a cross direction. For a circular barrier of extruded material, that mea~s that shrinkage will tend to be greater in one radial direction than another, whereas in a barrier embodying this invention, shrinkage is observed to be more uniform. Greater uniformity in other characteristics, such as fluid migration, swelling, absorption, and erosion is ill ~nhc~ ved to be more uniform in all radial directions than for extruded barriers, although the full extent thereof is not completely known.
With respect to molecular orientation, the data appearing in Figure 8 would suggest that the molecules of injection/compression molded barriers tend to be oriented in radial directions, since the vertical lines for sample batches C, D and E all extend above the vertical lines for batch A, meaning that the strength in all radial directions for hydrocolloid discs made in accordance with our process equals or exceeds the strength of a conventionally extruded disc in its machine direction -- its ~LVIl~ aL direction. The same observation cannot be made for the data appearing in Figure 7, but one important fact is evident from both figures, namely, that unlike an extruded barrier disc, discs formed by our process have an important physical characteristics (tensile strength) which relates directly to molecular orientation and which is subst~nt iAl ly uniform in all radial directions (for 360 degrees) in the relatively large annular outer zone 22 of the barrier disc 20 ' .
Referring to Figure 9, the numeral 30 generally designates an apparatus for carrying out the process of this invention.
The machine includes a stationary upper platen member 31 and a vertically-movable lower platen member 32. Hydraulic means 33, or other suitable driving means, intermittently raise and lower member 32, with the spacing between the generally horizontal opposing faces 31a and 32a of the respective members being shown 2 1. ~ O 1 6 6 at maximum distance in Figure 9. A web 34 from supply roll 35 extends across the face of the lower member and is ultima~ely re-rolled onto take-up roll 36. A second web 37 leads from supply roll 38 and over guide rollers 39-42 carried by the upper member, the web 39 then passing into the space between the two members and finally being rewound onto take-up roll 36. (Webs 34 and 37 are schematically shown slightly spaced apart adjacent the take-up roll only for clarity of illustration. ) Two sequential operating stations are provided by machine 30, the first station being an injection station in which a measured amount of barrier material is deposited onto the first web 34 and the second station being a ~ ulJL s,.ion molding station in which the deposited mass of barrier material is pressed into a desired shape between the first web 34 and the second web 37.
The operating elements at the injection station are conventional although their functions in carrying out the method of this invention are believed unique. Driving means 45 directs heated barrier material through passage 46 to nozzle 47. A gate valve 48 operated by air cylinder 49 and compressor 50, or by any other suitable means, intermittently raises and lowers the valve to allow measured quantities of barrier material to be discharged from the nozzle onto the lower first web 34 removably supported on the horizontal upper surface of member 32. The barrier material is stored and heated in a suitable reservoir 51. Heating increases the flowability of the barrier material, although the optimum temperature depends on the particular formulation involved. In general, temperatures in the range of 120 to 260- F. are believed effective.
At the ~ 3sing station, at least one of the members 31, 32 is provided with a die having a cavity in the shape of the wafer to be formed. In Figure 9, the die 55 is removably supported in a recess provided by the lower vertically-movable platen member 3 2 . The upper platen member 31 is stationary and has a flat face 56 parallel with die 55. The arrangment shown is believed to be particularly advantageous, but it is to be understood that, if desired, the upper member might instead be provided with the removable die 55 or, alternatively, both the ,~ ,.. . .
upper and lower members might be so provided. The arrangement shown especially useful for making contoured wafers of the type shown in Figures 2-4 in which only one side of each wafer is contoured or stepped and the opposite side is flat or planar.
Figures 10-13 illustrate the sequence of steps in the injection/compression molding of barrier wafers. In Figure 10, the valve gate is opened as platen member 32 ^~ ~c its downward stroke. Heated barrier material 60 is discharged from the nozzle 47 onto the first web 34, and such discharge continues until the spacing between the upper and lower members approaches its maximum. The valve then closes, leaving a mass or mound 61 of barrier material on web 34 ~Figure 11). It-. is to be noted that the second web 37 does not pass through the space in which the depositing of softened barrier material occurs ~ut instead converges towards web 34 in an area beyond the first station .
With the upper and lower platen members at maximum spacing, the two webs 34 and 37 are indexed forwardly to shift the mound 61 of barrier material into a central position over die plate 55. Since the upper web 37 also indexes forwardly, the mound or mass of barrier material is now l i eposed between the two ~iebs (Figure 12).
At this point, drive means 33 operates to shift the lower platen member 32 upwardly to reduce the spacing and compress the barrier material so that it flows outwardly in all radial directions within the mold cavity 58 (Figures 12, 13). The quantity of barrier material in mound 61 may be precisely controlled so as to just fill, or almost fill, the cavity space available for it. The result is that wastage of barrier material during s~lhs~ nt trimming operations is either completely eliminated or substantially avoided. Alternatively, the amount of barrier material may be controlled to slightly exceed the cavity space available for it, thereby causing a marginal flash of barrier material that must thereafter be trimmed away at a cutting station, but the amount of barrier so wasted would still be minimal and virtually insignificant in comparison with that commonly experienced in the die-cutting of extruded barrier materials.

The sequence is then repeated, with additional barrier material being deposited at the first station as the lower platen member 32 moves away from the upper platen member ~1 (Figure lo). The nearly finished wafer formed at the _~ssion station is removed from that station in the i~dexing step immediately following Figure 11.
F~eferring again to Figure 9, the finished wafers 10 ~re cut from the incrementally advancing webs by cutting rollers 60, 61 or by any other suitable cutting means . ~he r~~- i n~iPe of webs 34 amd 37 are wound onto take-up roller 36.
Other stations may be interposed between the compressing and cutting stations or may be located after the cutting station. For example, as represented by phantom lines 63 in Figure 9, a printing station may be interposed between the , ~ssing and cutting stations to print suitable indicia on one or both of the web portions that are to become the outer layers of the final wafers. Similarly, a processing station 64 may be located beyond the cutting station for attaching the wafers 10 to pouches or other articles, or for packaging the wafers into suitable wrappers, or for other processing operations. Stated difrerently, the injection/compressio~
molding system depicted in Figure 9, in combination with the cutting station and even the printing station 63, may be only the wafer-producing segment of a production line that then, utilizes such wafers in making products in which the wafers are only a part.
In addition to avoiding or reducing waste of relativ~ly expensive barrier material, the processing method disclosed herein has other important advantages over conventional extrusion methods. If, for example, it is desirable to interrupt the operation of the line to produce a quantity of wafers having a different contour, that may be accomplished simply by removing die 55 and replacing it with one having a cavity of different contour. C~LL~_IJOI-~;n~ changes may or may not have to be made at the inj ection station and cutting station, depending on whether the quantities of barrier material required for each wafer are the same and whether the outer diameters of the wafers are unchanged but, in any case, the ; ~ - . 2~01 ~6 changes required and the time needed for making them are far less than commonly encountered in changing f rom one product to another in a conventional extrusion operatiOn.
It i5 believed apparent that in the illustration given the material of web 37 ultimately becomes the releasable backing layer 12 for each of the finich.~d wafers and that the material of web 34 becomes the covering layer 13 for each such wafer. As already indicated, such materials may vary considerably der-~n~;n~ on product requirements but, in general, iP a product is to be contoured as depicted in Figures 2-4, the material selected for the col-LouLed side (or sides) of the wafer should be flexible and deformable so that it may readily assume the shape of the mold cavity at the compression molding station.
The injection and compression molding stations need not be spaced apart, even though the arrangement shown in Figures 9-13 is believed to be a preferred one . In a second - ~; r depicted in Figures 14-16, the two stations are combined with both injection (depositing of barrier material) and compression (contouring of the barrier material by radial displacement) oCcurring without forward ; n~-~Y; n~ of the webs .
In the method of the alternate od;r-nt, the lower web 134 may be identical to web 34 already described, but the upper or second web 137, unlike web 37, has spaced apertures or op~n;n~S 70. During the injecting step, heated barrier material 60 is discharged or <1; cp~n~:~d through a web opening 70 by no2zle 47 (Figure 15). When a mound of barrier material of sufficient volume has been discharged onto web 134, the lower platen member 132 is shifted upwardly towards the upper platen member 131 to close the spacing between the two platens and to force the barrier material radially outwardly in the directions of arrows 71 in Figure 16.
The lower platen member is provided with a removable mold 155 having a cavity 158 which may be identical to mold 55 with its cavity 58, the only difference being that mold 155 is arranged so that its center is directly below the inj ection opening of the upper web 137, and below injection nozzle 47, so that no forward ;nd~Y;nq is required between the injection and :ssion steps.

l b b It is believed apparent that the method steps depicted in Figures 15 and 16 could alternatively be carried out with the injecting steps and the compressing steps occurring at different stations in the same manner as indicated with respect to the first ~ o~ t. In that event, the only significant difference over the first ~ t would be that the upper we~
is perforated and passes through (rather than around) the injecting station, with barrier material then being dischArged through the or~n i n~c of the upper web in the manner depicted in Figure 15.
Whether there is wastage of barrier material during a cutting operation depends largely on the location of the cutting line. For example, Figure 17 depicts a wafer having an o~ter perimeter die cut along cutting line "d" in Figure 16. Barrier material extends to the cut edge of the fin;ch.od wafer, ard a slight amount of barrier material remains with the webs a~d must be discarded as scrap. On the other hand, if the cutting line i~ located further outwardly, at or just beyond the outer limits of the barrier material (as represented by "d"' in Figure 16), then there will be no wastage at all of barrier material and the f;n;clled product will have an appearance more similar to that depicted in Figure 18. Under such conditions, the barrier material may terminate short of the outer limits of the wafer, and the outer layers of the wafer may contact each other beyond the peripheral limits of the barrier material.
While in the foregoing, we have disclosed embodiments of the invention in considerable detail for purposes of illustration, it will be understood ~y those slcilled in the art that many of these details may be varied without departing from the spirit and scope of the invention.

Claims (19)

1. An adhesive wafer comprising (a) a thin barrier layer of soft, pliant, adhesive material having particles of one or more hydrocolloids dispersed therein and having upper and lower surfaces, (b) a flexible cover layer extending over one of said surfaces of said barrier layer, and (c) a removable release sheet extending over the other of said surfaces of said barrier layer; wherein the improvement comprises said wafer having a central zone and an annular outer zone; said material of said barrier layer in said outer zone being of generally uniform molecular orientations in radial directions over an arc of 360° about said central zone and being of substantially uniform tensile strength when measured in all of said radial directions.
2. The wafer of Claim 1 in which the area of said outer zone is substantially greater than that of said central zone.
3. The wafer of Claim 1 in which at least one of said surfaces of said barrier layer is contoured and said cover layer or said release sheet in contact therewith follows the contour of said barrier layer.
4. A method of making a wafer having a core layer of skin barrier material and at least two outer layers on opposite sides of skin barrier layer, comprising the steps of depositing a mound of soft, deformable skin barrier material onto a flexible first web extending generally along a horizontal plane and supported by a first platen; locating a flexible second web above said first web and said mound, with said second web being backed by a second platen position directly thereabove;
and thereafter reducing the spacing between said first and second platens and compressing said mound of skin barrier material to displace a major portion of said mound of skin barrier material radially outwardly in directions extending 360°

about the original location of the deposit of said mound.
5. The method of Claim 4 in which at least one of said platens has a mold cavity of selected shape facing in the direction of said webs.
6. The method of Claim 5 in which said mold cavity has an outline defining the shape of a wafer and said mound is located centrally with respect to said cavity at the commencement of said step of compressing said mound.
7. The method of Claim 5 in which said depositing step includes depositing only a preselected quantity of said skin barrier material sufficient to cause displacement of said skin barrier material up to or slightly beyond the outer limits of said mold cavity.
8. The method of Claim 5 in which said cavity is provided by said first platen.
9. The method of Claims 5 or 8 in which said first platen is movable towards and away from said second platen, and said compressing step comprises moving said first platen upwardly towards said second platen while the position of said second platen remains fixed.
10. The method of Claim 4 in which said step of locating said second web above said first web and above said mound occurs at the same time said mound is deposited onto said first web.
11. The method of Claim 10 in which said second web is provided with an aperture and said skin barrier material is forced through said aperture onto said first web during said depositing step.
12. The method of Claim 4 in which said second step of locating said second web above said first web and above said mound occurs after completion of said step of depositing said mound of skin barrier material onto said second web.
13. The method of Claim 12 in which said depositing step occurs at a first operating station and said locating and compressing steps occur at a second operating station; said first web being advanced from said first station to said second station after said depositing step is completed.
14. The method of Claim 13 in which said second web is imperforate.
15. The method of Claim 4 in which said skin barrier-material is heated above ambient temperature to increase its flowability; said skin barrier material being in a heated state of increased flowability during said depositing, locating, and compressing steps.
16. The method of Claim 4 in which there is the further step of cutting said wafer from said webs after said step of compressing and radially displacing the material of said mound.
17. The method Claim 16 in which said cutting step includes cutting along a line within the limits of outward displacement of said skin barrier material.
18. The method of Claim 16 in which said cutting step includes cutting said webs along a line outside of the limits of outward displacement of said skin barrier material.
19. The method of Claim 16 in which said cutting step also includes the further step of simultaneously cutting a central opening in said wafer.
CA002180166A 1995-08-01 1996-06-27 Wafer having adhesive skin barrier layer and production method therefor Abandoned CA2180166A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/510,035 US5609585A (en) 1995-08-01 1995-08-01 Wafer having adhesive skin barrier layer
US510,035 1995-08-01

Publications (1)

Publication Number Publication Date
CA2180166A1 true CA2180166A1 (en) 1997-02-02

Family

ID=24029097

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002180166A Abandoned CA2180166A1 (en) 1995-08-01 1996-06-27 Wafer having adhesive skin barrier layer and production method therefor

Country Status (7)

Country Link
US (2) US5609585A (en)
EP (1) EP0756854B2 (en)
JP (1) JPH09154866A (en)
CA (1) CA2180166A1 (en)
DE (1) DE69602402T3 (en)
DK (1) DK0756854T4 (en)
MX (1) MXPA96003123A (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08335539A (en) * 1995-06-06 1996-12-17 Sony Corp Production control apparatus and production control method
US5811116A (en) * 1996-04-30 1998-09-22 Hollister Incorporated Adhesive wafer with embossed skin-contacting surface
US5730736A (en) * 1996-04-30 1998-03-24 Dansac A/S Ostomy appliance and contoured adhesive wafer therefor
US6093276A (en) 1998-06-11 2000-07-25 Hollister Incorporated In-line method of manufacture of ostomy appliance faceplate
US6106507A (en) 1998-06-11 2000-08-22 Hollister Incorporated Ostomy appliance faceplate with barrier layer, extended covering layer, and unitary protective release sheet and method of making
US6293930B1 (en) * 1998-06-11 2001-09-25 Hollister Incorporated Low-profile ostomy faceplate with recessed coupling ring
WO2000018554A1 (en) 1998-09-25 2000-04-06 Coloplast A/S A method for producing a layered product
US6309500B1 (en) * 1998-11-02 2001-10-30 Robert Jensen Method for manufacturing contoured and laminated materials
ATE293659T1 (en) * 1998-11-03 2005-05-15 Bristol Myers Squibb Co HYDROCOLLOID ADHESIVE COMPOSITIONS
US6825246B1 (en) 1998-11-03 2004-11-30 Bristol-Myers Squibb Company Hydrocolloid adhesive compositions
GB9905313D0 (en) * 1999-03-09 1999-04-28 Welland Medical Ltd Ostomy bags
AU3302800A (en) 1999-03-09 2000-09-28 Welland Medical Limited Adhesive pads for ostomy bags
US6569134B1 (en) * 2000-06-14 2003-05-27 Hollister Incorporated Reformable convex adapter for ostomy appliance and method of use
US6740067B2 (en) 2000-06-14 2004-05-25 Hollister Incorporated Reformable convex adapter for ostomy appliance
US6790200B2 (en) * 2001-01-11 2004-09-14 Marlen Manufacturing And Development Co., Inc. Ostomy pouch and method of assembly
US6919492B2 (en) 2001-06-13 2005-07-19 Hollister Incorporated Skin barrier strip having triangular cross section
US20030125680A1 (en) * 2002-01-02 2003-07-03 Ding Jian Ling Hydrocolloid bandage
US20030171737A1 (en) * 2002-03-11 2003-09-11 Leise, Walter F. Soft convex adhesive wafer
US6840924B2 (en) * 2002-07-03 2005-01-11 Bristol-Myers Squibb Company Ostomy appliance
DK200201659A (en) 2002-10-31 2004-05-01 Coloplast As An ostomy device comprising a collection bag and a base plate as well as an ostomy collection bag
US6746765B1 (en) 2003-01-23 2004-06-08 Bristol-Myers Squibb Company Hydrocolloid adhesive tape
DK176790B1 (en) * 2003-03-31 2009-09-07 Coloplast As Sticky patch
EP2170413B1 (en) * 2007-06-19 2014-03-12 Coloplast A/S Multi-layered adhesive appliance
JP5269986B2 (en) 2008-05-30 2013-08-21 ケーシーアイ ライセンシング インコーポレイテッド Linear wound closure cushion and system under reduced pressure
BRPI0909606A2 (en) 2008-05-30 2016-02-16 Kci Licensing Inc system for providing strength to a desired treatment area in a curved body part of a person, system for providing compression force to a desired treatment area on a person's torso, method for manufacturing a system for providing compression force to a person desired treatment area in a curved part of a person's body
CA2742900A1 (en) 2008-12-08 2010-06-17 Esben Stroebech A body waste collecting device comprising a layered adhesive construction with a film layer
JP4696164B2 (en) * 2009-01-30 2011-06-08 池田機械産業株式会社 Emergency bandage production equipment
GB2473667B (en) * 2009-09-22 2015-11-18 Salts Healthcare Ltd Adhesive member
KR101287299B1 (en) * 2010-05-28 2013-07-17 이케다 기카이 산쿄 가부시키가이샤 Device for producing first-aid adhesive tape
US9827146B2 (en) * 2011-12-20 2017-11-28 Sarasota Medical Products, Inc. Manufacturing method for wound dressings
DK2819627T3 (en) * 2012-02-29 2020-02-03 Hollister Inc Cached Adhesive Compositions for Skin Adhesive Medical Products
US10470936B2 (en) 2012-02-29 2019-11-12 Hollister Incorporated Buffered adhesive compositions for skin-adhering medical products
CN104244879B (en) * 2012-04-20 2017-09-26 科洛普拉斯特公司 Adhesive sheet
RU2648225C2 (en) * 2013-01-29 2018-03-22 Колопласт А/С Ostomy appliance
USD753820S1 (en) * 2013-06-26 2016-04-12 Coloplast A/S Ostomy bag
USD746978S1 (en) * 2013-06-26 2016-01-05 Coloplast A/S Ostomy bag

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1084708A (en) * 1912-07-02 1914-01-20 Frederick Stearns & Company Method of forming wafer-capsules.
US2098395A (en) * 1933-08-24 1937-11-09 Law James Allan Process of and apparatus for molding hollow rubber articles
JPS59174320A (en) * 1983-03-24 1984-10-02 Yoshino Kogyosho Co Ltd Method of forming circular sheet body
US4738257A (en) * 1986-06-11 1988-04-19 Hollister Incorporated Occlusive wound care dressing
DK154747C (en) * 1986-10-17 1989-05-08 Coloplast As BANDAGE WITH A SKIN-FRIENDLY, WATER-ABSORBING CLOTH DISC WHICH IS ON THE SURFACE IS STRONGLY ASSOCIATED WITH A NON-CLASSIC COVERAGE AND ON THE OTHER WITH A REMOVABLE PROTECTIVE COVER
US4952618A (en) * 1988-05-03 1990-08-28 Minnesota Mining And Manufacturing Company Hydrocolloid/adhesive composition
US5074944A (en) * 1988-05-27 1991-12-24 Smith & Nephew United, Inc. Method for manufacturing a layered article having a beveled edge
US5133821A (en) * 1990-11-19 1992-07-28 Jensen Ole R Method for contouring hydrocolloid wound dressings
DE69228846T2 (en) * 1991-07-22 1999-08-05 Nitto Denko Corp Association
US5332613A (en) * 1993-06-09 1994-07-26 Kimberly-Clark Corporation High performance elastomeric nonwoven fibrous webs

Also Published As

Publication number Publication date
DE69602402T2 (en) 1999-09-09
EP0756854B1 (en) 1999-05-12
US5716475A (en) 1998-02-10
DE69602402D1 (en) 1999-06-17
US5609585A (en) 1997-03-11
EP0756854B2 (en) 2005-03-09
DK0756854T3 (en) 1999-11-01
EP0756854A1 (en) 1997-02-05
DE69602402T3 (en) 2005-07-07
MXPA96003123A (en) 2004-12-03
DK0756854T4 (en) 2005-06-20
JPH09154866A (en) 1997-06-17

Similar Documents

Publication Publication Date Title
EP0756854B2 (en) Wafer having adhesive skin barrier layer
JPH024416B2 (en)
JP4510641B2 (en) Method and apparatus for packaging hot melt adhesives using a mold and a carrier
KR100489857B1 (en) Low stress relaxation elastomeric film and article comprising the same
EP0236402B1 (en) Contoured film
US5593628A (en) Method of making an orthopedic casting article comprising an apertured, extruded sheet
US6303208B1 (en) Breathable elastic polymeric film laminates
EP1033119B1 (en) Ostomy appliance
JPS59205959A (en) Dressing
JP2003533374A (en) Three-dimensional highly elastic film / nonwoven composite
US6191336B1 (en) Method of heat-sealing adhesive bandage and adhesive bandage made by using said method
JP2009521964A (en) Layered adhesive composition having a moldable layer as a skin contact surface
CN1217788C (en) Radiation crosslinked elastomeric materials
US5935363A (en) Process for making contoured hydrocolloid-containing adhesive dressings
WO1998056583A1 (en) An improved method of making breast enhancers
JPH10504266A (en) Method of applying elastic member to moving substrate
JP2632511B2 (en) Three-dimensional printed fabric molded body and method of manufacturing the same
US9827146B2 (en) Manufacturing method for wound dressings
CN113143377B (en) Hemostatic material belt for plastic surgery
KR101973088B1 (en) Punching machine for folding mask pack
JP4143784B2 (en) Prosthetic material for automatic suturing device
JP4199527B2 (en) Hemostasis member and method of using the same
EP0818187B1 (en) Process for making contoured hydrocolloid-containing adhesive dressings
CN217771716U (en) NBR or SBR powder puff
AU780014B2 (en) Method of heat sealing adhesive bandage and adhesive bandage made by using said method

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20000627